The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLSDays features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Dr. Mervi Aavikko

Project Manager FinnGen, University of Helsinki

20 Apr 11:15 Plenary Room Super Session 1

Dr. Ingrid Teigland Akay

Managing Partner, Hadean Ventures

21 Apr 09:15 Plenary Room Super Session 4

Dr. Sonia Benhamida

Senior Vice President Healthcare, DNB

21 Apr 09:15 Plenary Room Super Session 4

Dr. Magnus Björsne

CEO, Astrazeneca BioVentureHub

21 Apr 13:45 Plenary Room Super Session 6

Dr. Nikolai Brun

Chair HMA-EMA Taskforce on Big Data

20 Apr 11:15 Plenary Room Super Session 1

Ms. Karin Conde-Knape

CVP Global Diabetes, Cardio-Renal and Global Drug Discovery, Novo Nordisk

21 Apr 11:15 Plenary Room Super Session 5

Ms. Isabelle de Cremoux

CEO & Managing Partner, Seventure Partners

21 Apr 09:15 Plenary Room Super Session 4

Dr. Eric De La Fortelle

Venture Partner Seventure Partners

20 Apr 13:45 Plenary Room Super Session 2

Mr. Olivier Duchamp

Managing Director, NLSDays - NLS Invest

20 Apr 09:30 Plenary Room Opening Plenary

Mr. Erik Gatenholm

CEO and Co-Founder, Cellink

20 Apr 09:30 Plenary Room Opening Plenary

Dr. Gianfranco Grompone

Chief Scientific Officer, BioGaia

20 Apr 13:45 Plenary Room Super Session 2

Ms. Carolina Haefliger

VP, Head Centre for Genomics Research, AstraZeneca

21 Apr 11:15 Plenary Room Super Session 5

Dr. Rafiq Hasan

CEO, ExACT Therapeutics

20 Apr 09:30 Plenary Room Opening Plenary

Ms. Sarah Lidé

Senior Strategy & Project Manager, Medicon Valley Alliance

20 Apr 13:45 Plenary Room Super Session 2

Mr. Emmanuel Ligner

CEO & President at Cityva (former GE Healthcare Life Sciences)

20 Apr 09:30 Plenary Room Opening Plenary

Dr. Elisabeth Liljensten

CEO, Devicia

21 Apr 13:45 Plenary Room Super Session 6

Dr. Lars Lindsköld

Portfolio manager, Sweper / Swelife

20 Apr 11:15 Plenary Room Super Session 1

Ms. Rajji Mehdwan

General Manager, Roche Norway

20 Apr 11:15 Plenary Room Super Session 1

Dr. Mirjam Mol-Arts

SVP Global Development, Ferring Pharmaceuticals

20 Apr 13:45 Plenary Room Super Session 2

Dr. Henrik Bjørn Nielsen

Chief Scientific Officer, Clinical Microbiomics

20 Apr 13:45 Plenary Room Super Session 2

Dr. Sam Oddsson

Chief Medical Officer & Co-Founder, SidekickHealth

21 Apr 13:45 Plenary Room Super Session 6

Mr. Martin Olovsson

CEO and Co-Founder, Ondosis

21 Apr 13:45 Plenary Room Super Session 6

Ms. Louise Rosenlund Nielsen

Head of International Development & Partnerships, CopCap

20 Apr 11:15 Plenary Room Super Session 1

Dr. Jessica Shull

European Lead, Digital Therapeutics Alliance

21 Apr 13:45 Plenary Room Super Session 6

Dr. Patrick Sobocki

Investment Manager, Industrifonden

21 Apr 11:15 Plenary Room Super Session 5

Ms. Helena Strigård

Director General, SwedenBIO

20 Apr 09:30 Plenary Room Opening Plenary

Dr. Lennart Thurfjell

CEO, Combinostics

Dr. Christina Trojel-Hansen

CEO and Co-Founder - Oscine Therapeutics, in Residence - Arch Venture Partners

21 Apr 09:15 Plenary Room Super Session 4

Mr. Claes Watndal

CEO, Mentis Cura